524661 — Welcure Drugs and Pharmaceuticals Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
IN₹83.15m
Enterprise Value
IN₹1.12bn
Revenue
IN₹245.50m

Annual income statement for Welcure Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	R2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	Interim Report	ARS	ARS
Standards:	IAS	IAS	—	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1.33	1.05	0	0	246
Cost of Revenue
Gross Profit	—	—	0	—	40.5
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	0.784	0.814	1.22	2.69	237
Operating Profit	0.549	0.236	-1.22	-2.69	8.7
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.551	0.236	-0.526	-1.75	27.8
Provision for Income Taxes
Net Income After Taxes	0.551	0.236	-0.526	-1.75	21.7
Net Income Before Extraordinary Items
Net Income	0.551	0.236	-0.526	-1.75	21.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.551	0.236	-0.526	-1.75	21.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.045	0.019	-0.004	-0.129	0.278